Sunday, June 23, 2024
spot_img
HomeNewsGlobal NewsCanada: Lutetium-177 will be used to treat a range of cancers including...

Canada: Lutetium-177 will be used to treat a range of cancers including prostate cancer and neuroendocrine tumours

TORONTO, Canada – The Ontario government is welcoming the installation of a second isotope production line at Bruce Power that will double the power plant’s ability to produce the medical isotope lutetium-177. This increased production will help meet growing demand for lutetium-177 which is used as a targeted therapy for a range of cancers, including prostate cancer and neuroendocrine tumours.

“[Today’s] announcement is an exciting development that highlights the many benefits of nuclear power, including the expanded production of life-saving medical isotopes,” said premier Ford. “Our government is proud to support the expansion of nuclear power as part of our plan to bring safe, reliable and affordable energy, along with cutting-edge cancer treatments, to families across Ontario. I would like to congratulate Bruce Power, Isogen, Saugeen Ojibway Nation and ITM for delivering this incredible expansion, cementing Ontario’s place as a global leader in the production of cancer-fighting medical isotopes.”

Bruce Power is installing the second isotope production system in collaboration with the Saugeen Ojibway Nation, Isogen and ITM, with the upgrades on track to be completed before the end of 2024. This comes after the installation of the existing system in 2022 which made Bruce Power the first commercial power reactor in the world to produce lutetium-177.

“Not only are Ontario’s nuclear reactors providing more than 50 per cent of the province’s electricity, but they are also producing life-saving medical isotopes that are helping to diagnose and treat prostate cancer, neuroendocrine tumors and other diseases,” said Todd Smith, minister of energy. “Our government is proud to invest in nuclear energy as partnerships like this are playing an important role in the incredible transformation of health care.”

“Bruce Power is proud of our long legacy as a key producer of medical isotopes, which are used globally in the fight against cancer,” said Mike Rencheck, Bruce Power president and CEO. “Together with our partners, we are continuing to expand our capabilities to supply the isotopes needed to meet demand and advance research in cancer treatments and procedures to help save lives.”

Leaders from Saugeen Ojibway Nation (SON), which jointly markets isotopes produced through the isotope production system installed at Bruce Power, also attended the celebration. The Gamzook’aamin aakoziwin partnership supports the global fight against cancer while creating new, meaningful economic opportunities within SON territory.

As part of Powering Ontario’s Growth, the government’s pragmatic plan which outlines the actions the province is taking to meet growing energy demand, the government is making significant investments in nuclear energy and the 65,000 Ontario jobs supported by the sector, including:

spot_img
RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

spot_img
spot_img
spot_img

Caribbean News

BVI – UN Refugee Agency strengthens ties

By Government of the British Virgin Islands TORTOLA, BVI - The British Virgin Islands (BVI) and United Nations High Commissioner for Refugees (UNHCR) have pledged...

Global News